Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Chou-Talalay-Methode× | Michaelis-Menten-Kinetik× | Populationspharmakodynamische Modellierung× | |
|---|---|---|---|
| Fachgebiet | Pharmakologie | Pharmakologie | Pharmakologie |
| Familie | Process / pipeline | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 1983 | 1913 | 1992 |
| Urheber≠ | Ting-Chao Chou and Paul Talalay | Leonor Michaelis and Maud Menten | Lewis Sheiner and Stephen Roush |
| Typ≠ | synergy quantification | mechanistic model | dose-response modeling |
| Wegweisende Quelle≠ | Chou, T. C., & Talalay, P. (1983). Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation, 22, 27-55. DOI ↗ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Aliasnamen | CI method, Chou method, median-effect analysis | MM kinetics, Michaelis constant, Vmax | PopPD, population PD, hierarchical PD modeling |
| Verwandt≠ | 3 | 2 | 3 |
| Zusammenfassung≠ | The Chou-Talalay method is a quantitative framework for analyzing drug interactions, developed by Ting-Chao Chou and Paul Talalay in 1983. It combines median-effect principle with the combination index (CI) to provide rigorous, model-independent assessment of synergistic, additive, or antagonistic drug effects. | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateDatensatz ↗ |
|
|
|